Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 3
2005 2
2006 3
2007 2
2008 1
2009 5
2010 1
2011 5
2012 2
2013 2
2014 4
2015 5
2016 10
2017 6
2018 6
2019 2
2020 2
2021 4
2022 2
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

65 results
Results by year
Filters applied: . Clear all
Page 1
Aptamers: Cutting edge of cancer therapies.
Shigdar S, Schrand B, Giangrande PH, de Franciscis V. Shigdar S, et al. Among authors: de franciscis v. Mol Ther. 2021 Aug 4;29(8):2396-2411. doi: 10.1016/j.ymthe.2021.06.010. Epub 2021 Jun 17. Mol Ther. 2021. PMID: 34146729 Free PMC article. Review.
Nucleic acids delivering nucleic acids.
Catuogno S, Esposito CL, Condorelli G, de Franciscis V. Catuogno S, et al. Among authors: de franciscis v. Adv Drug Deliv Rev. 2018 Sep;134:79-93. doi: 10.1016/j.addr.2018.04.006. Epub 2018 Apr 6. Adv Drug Deliv Rev. 2018. PMID: 29630917 Review.
Challenging cancer targets for aptamer delivery.
de Franciscis V. de Franciscis V. Biochimie. 2018 Feb;145:45-52. doi: 10.1016/j.biochi.2017.09.014. Epub 2017 Sep 28. Biochimie. 2018. PMID: 28962871 Review.
Cell-specific aptamers for targeted therapies.
Cerchia L, Giangrande PH, McNamara JO, de Franciscis V. Cerchia L, et al. Among authors: de franciscis v. Methods Mol Biol. 2009;535:59-78. doi: 10.1007/978-1-59745-557-2_5. Methods Mol Biol. 2009. PMID: 19377980 Free PMC article. Review.
Aptamer-Mediated Targeted Delivery of Therapeutics: An Update.
Catuogno S, Esposito CL, de Franciscis V. Catuogno S, et al. Among authors: de franciscis v. Pharmaceuticals (Basel). 2016 Nov 3;9(4):69. doi: 10.3390/ph9040069. Pharmaceuticals (Basel). 2016. PMID: 27827876 Free PMC article. Review.
Structure- and Interaction-Based Design of Anti-SARS-CoV-2 Aptamers.
Mironov V, Shchugoreva IA, Artyushenko PV, Morozov D, Borbone N, Oliviero G, Zamay TN, Moryachkov RV, Kolovskaya OS, Lukyanenko KA, Song Y, Merkuleva IA, Zabluda VN, Peters G, Koroleva LS, Veprintsev DV, Glazyrin YE, Volosnikova EA, Belenkaya SV, Esina TI, Isaeva AA, Nesmeyanova VS, Shanshin DV, Berlina AN, Komova NS, Svetlichnyi VA, Silnikov VN, Shcherbakov DN, Zamay GS, Zamay SS, Smolyarova T, Tikhonova EP, Chen KH, Jeng US, Condorelli G, de Franciscis V, Groenhof G, Yang C, Moskovsky AA, Fedorov DG, Tomilin FN, Tan W, Alexeev Y, Berezovski MV, Kichkailo AS. Mironov V, et al. Among authors: de franciscis v. Chemistry. 2022 Feb 24;28(12):e202104481. doi: 10.1002/chem.202104481. Epub 2022 Feb 9. Chemistry. 2022. PMID: 35025110 Free PMC article.
Nucleic acid aptamers in cancer medicine.
Cerchia L, Hamm J, Libri D, Tavitian B, de Franciscis V. Cerchia L, et al. Among authors: de franciscis v. FEBS Lett. 2002 Sep 25;528(1-3):12-6. doi: 10.1016/s0014-5793(02)03275-1. FEBS Lett. 2002. PMID: 12297271 Free article. Review.
65 results